CureVac N.V. (FRA:5CV)
4.516
-0.100 (-2.17%)
Oct 23, 2025, 11:10 AM CET
CureVac Employees
As of December 31, 2024, CureVac had 983 total employees, including 825 full-time and 158 part-time employees. The number of employees decreased by 189 or -16.13% compared to the previous year.
Employees
983
Change (1Y)
-189
Growth (1Y)
-16.13%
Revenue / Employee
€564,722
Profits / Employee
€214,201
Market Cap
1.04B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 983 | -189 | -16.13% |
| Dec 31, 2023 | 1,172 | 123 | 11.73% |
| Dec 31, 2022 | 1,049 | 165 | 18.67% |
| Dec 31, 2021 | 884 | 330 | 59.57% |
| Dec 31, 2020 | 554 | 100 | 22.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 176,486 |
| Fresenius Medical Care AG | 111,513 |
| Bayer Aktiengesellschaft | 91,864 |
| Siemens Healthineers AG | 72,000 |
| Merck KGaA | 59,020 |
| Fielmann Group AG | 24,363 |
| Sartorius Aktiengesellschaft | 13,528 |
| Carl Zeiss Meditec AG | 5,730 |
CureVac News
- 22 days ago - CureVac: The Hidden Value Of The mRNA Wallet - Seeking Alpha
- 2 months ago - CureVac BV reports Q2 results - Seeking Alpha
- 2 months ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Wallstreet:Online
- 2 months ago - CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Accesswire
- 2 months ago - CureVac's 2025 Mid-Year Financial Surge & Key Business Insights - Wallstreet:Online
- 2 months ago - EQS-News: CureVac Announces Financial Results for the Second Quarter and First Half of 2025 and Provides Business Updates - Wallstreet:Online
- 2 months ago - GSK, CureVac to receive $740M as COVID vaccine patent dispute with Pfizer, BioNTech settled - Seeking Alpha
- 2 months ago - GSK to be paid up to £370 million after patent row settles in US - Evening Standard